The Menopause Society's 2022 Hormone Therapy Position Statement advises that women aged older than 65 years can continue using hormone therapy (HT)...
Vous n'êtes pas connecté
WEDNESDAY, Sept. 11, 2024 -- Many women older than 65 years have validated menopausal symptoms severely affecting their quality of life and continue to use menopausal hormone therapy (MHT), according to a study presented at the annual meeting of the...
The Menopause Society's 2022 Hormone Therapy Position Statement advises that women aged older than 65 years can continue using hormone therapy (HT)...
TUESDAY, Sept. 10, 2024 -- Menopausal hormone therapy (HT) usage rates declined from 2007 to 2023 and remain low, according to a study presented at...
The Menopause Society's 2022 Hormone Therapy Position Statement advises that women aged older than 65 years can continue using hormone therapy (HT)...
WEDNESDAY, Sept. 11, 2024 -- Hormone therapy (HT) is associated with significantly reduced insulin resistance in healthy postmenopausal women,...
TUESDAY, Sept. 3, 2024 -- Postmenopausal women who use hormone therapy (HT) are biologically younger than those not receiving HT, according to a...
THURSDAY, Sept. 12, 2024 -- Statin therapy improves health outcomes and is cost-effective for men and women aged 70 years and older, according to a...
A new study shows that women can have menopause symptoms, like hot flashes, for longer than expected. Because of this, more research is looking at...
MONDAY, Sept. 16, 2024 -- A self-reported history of gestational hypertension is associated with cardiovascular disease (CVD) in postmenopausal...
MONDAY, Sept. 16, 2024 -- A self-reported history of gestational hypertension is associated with cardiovascular disease (CVD) in postmenopausal...
All doses of tirzepatide, a medication approved in the EU to treat type 2 diabetes and obesity, consistently reduced body weight in women and men, but...